Current Edition

US Enhances Malaria-fightingtoolkit
Volume 10 Issue 5

US Enhances Malaria-fighting Toolkit

The (FDA) asked an advisory committee to meet twice in two weeks to discuss nearly identical products with similar indications from two different pharmaceutical companies. …

Continue Reading →
Innovative approaches in early-phase
Volume 10 Issue 5

Innovative Approaches in Early-phase and First in Human Clinical Trials

There are many challenges that clinical research may face, and there is a risk of failure along the many phases of development. For a trial …

Continue Reading →
Harnessing social media to reach
Volume 10 Issue 5

Harnessing Social Media to Reach Today’s Social Media-savvy Rare Disease Patient and Caregiver

For patients with rare diseases, social media conversations are a gateway to uncovering information regarding condition coping and treatment. Likewise, for those who recruit for …

Continue Reading →
An interprofessional model for cardiac
Volume 10 Issue 5

An Interprofessional Model for Cardiac Safety Education

Since its formalisation in 2006, the Cardiac Safety Research Consortium (CSRC) has facilitated research projects, think tanks, and many publications in medical and scientific journals …

Continue Reading →
Diabetes research using new data models
Volume 10 Issue 5

Diabetes Research Using New Data Models Makes Fresh Research Connections

The emergence of Big Data and other advances in data science approaches and tools are providing medical researchers with the opportunity for previously unobtainable insight …

Continue Reading →
Pharmacovigilance in the European union
Volume 10 Issue 5

Pharmacovigilance in the European Union

In 2012, the European Union (EU) introduced regulatory controls for good pharmacovigilance practices (GVPs) to its member states. Since then, pharma businesses operating in the …

Continue Reading →
Landscape of early-phase oncology
Volume 10 Issue 5

Landscape of Early-phase Oncology Studies in the Netherlands

The Netherlands has been a natural favourite for conducting clinical research with the Dutch healthcare system ranking among the best in Europe, the high level …

Continue Reading →
The journey to clinic and beyond
Volume 10 Issue 5

The Journey to Clinic and Beyond

The formulation of a candidate drug for first in human (FIH) trials is of great importance – how a pharmaceutical company chooses to approach this …

Continue Reading →
Clinical development in rare diseases
Volume 10 Issue 5

Clinical Development in Rare Diseases: Idiopathic Pulmonary Fibrosis

IPF is a rare disease, in which patients are most often affected from middle age, and its manifestation is characterised by severe, irreversible interstitial fibrosis …

Continue Reading →
The evolving clinical trial landscape
Volume 10 Issue 5

The Evolving Clinical Trial Landscape in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis is a neurodegenerative disorder affecting predominantly central and peripheral motor neurons, resulting in progressive weakness and atrophy of voluntary skeletal muscle. It …

Continue Reading →